KNTE
Kinnate Biopharma Inc.
No insider bought or sold Kinnate Biopharma Inc. in the last 12 months
KNTE over the last year
Prices for KNTE aren't in yet.
KNTE after insider buys
3 months after each buy, from the first price a copier could get.
5 buys since 2020 with 3 months of prices.
Every filing
12 insider filings since 2020, newest first
James B. Tananbaum · Director and 10% owner
Foresite Capital Management Iv, LLC · 10% owner
Orbimed Advisors LLC · Director and 10% owner
Carl L Gordon · Director and 10% owner
Orbimed Advisors LLC · Director and 10% owner
Carl L Gordon · Director and 10% owner
Richard Thomas Williams · Chief Medical Officer
Orbimed Advisors LLC · Director
Carl L Gordon · Director
Orbimed Advisors LLC · Director and 10% owner
Carl L Gordon · Director and 10% owner
James B. Tananbaum · Director and 10% owner
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.